Perfusable Vascular Network with a Tissue Model in a Microfluidic Device
April 4th, 2018
14K views
The protocol describes how to engineer a perfusable vascular network in a spheroid. The spheroid's surrounding microenvironment is devised to induce angiogenesis and connect the spheroid to the microchannels in a microfluidic device. The method allows the perfusion of the spheroid, which is a long-awaited technique in three-dimensional cultures.
Overview
This protocol outlines the engineering of a perfusable vascular network within a spheroid using a microfluidic platform. The method facilitates the simulation of drug delivery directly into spheroids, addressing important questions in tissue modeling.
Key Study Components
Area of Science
- Microfluidics
- Vascular biology
- Tissue engineering
Background
- Understanding vascular networks is crucial for in vivo and in vitro tissue models.
- Perfusion in three-dimensional cultures has been a long-awaited technique.
- The method enhances the study of drug and supplement administration routes.
- Challenges exist in cell introduction into microfluidic devices.
Purpose of Study
- To construct a perfusable vascular network in multicellular aggregates.
- To simulate drug delivery in vitro.
- To improve understanding of vascular networks in regenerative medicine.
Methods Used
- Utilization of a microfluidic platform for network construction.
- PDMS prepolymer casting and curing.
- Degassing in a vacuum chamber.
- Creating holes in PDMS for cell introduction.
Main Results
- The method successfully creates a perfusable vascular network.
- Drug delivery can be effectively simulated in spheroids.
- Challenges in cell introduction were identified and addressed.
- This technique enhances the relevance of in vitro models.
Conclusions
- The protocol provides a valuable tool for studying vascular networks.
- It opens new avenues for research in regenerative medicine.
- Further optimization may improve cell introduction techniques.
Frequently Asked Questions
What is the main goal of this protocol?
The main goal is to construct a perfusable vascular network in spheroids using a microfluidic platform.
Why is vascular network modeling important?
It is crucial for understanding tissue behavior in both in vivo and in vitro environments.
What challenges are associated with this method?
Introducing cells into the microfluidic device can be difficult for beginners.
How does this method simulate drug delivery?
It allows for targeted delivery of drugs directly into the spheroids.
What materials are used in this protocol?
PDMS prepolymer is primarily used for creating the microfluidic device.
What are the advantages of using a microfluidic platform?
It enables precise control over the microenvironment and fluid delivery.
Executive Industry Relevance
Integrating a perfusable vascular network within spheroid tissue models addresses a critical barrier in recapitulating in vivo-like nutrient and waste exchange for drug discovery and tissue engineering. This microfluidic approach enables simulation of physiological perfusion, supporting predictive confidence in compound delivery and tissue response studies. The platform enhances translational relevance for early-stage screening and mechanistic de-risking in regenerative medicine and biopharma R&D portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of vascularization's role in tissue function and drug response.
- Supports mechanistic de-risking by modeling nutrient and waste exchange in 3D systems.
- Improves predictive confidence for target validation in complex tissue environments.
Screening & Assay Development
- Facilitates preparation of physiologically relevant, perfusable spheroid models for compound evaluation.
- Enables quantitative assessment of drug delivery and distribution within tissue constructs.
- Supports reproducible assay development by standardizing vascular integration in microfluidic devices.
Translational & Preclinical Research
- Provides a platform for disease-relevant modeling of vascularized tissues in vitro.
- Enables continuity from discovery to preclinical validation by mimicking in vivo perfusion.
- Reduces translational risk by aligning in vitro models with physiological tissue architecture.
Pipeline & Workflow Integration
This microfluidic vascularization method fits from early discovery through lead identification and preclinical validation, supporting hypothesis testing and translational continuity.
- Discovery Biology: Advances hypothesis testing on vascular function and tissue viability in engineered models.
- Screening: Delivers assay-ready, perfusable spheroids for robust compound screening.
- Analytics: Provides quantitative perfusion and distribution readouts for comparative analysis.
- Translational Research: Bridges in vitro and in vivo studies by replicating physiological perfusion.
- Enterprise Reuse: Establishes a reusable microfluidic platform adaptable to diverse tissue and disease models.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in tissue-based assays.
- Operational Value: Standardizes vascularized tissue model preparation for scalable workflows.
- Strategic Value: Improves go/no-go decisions by providing physiologically relevant data early in the pipeline.
- Portfolio Impact: Enables risk-adjusted prioritization of candidates based on more predictive in vitro models.
Implementation Considerations
- Requires expertise in microfluidics, cell culture, and tissue engineering.
- Needs access to microfabrication tools and imaging infrastructure for monitoring perfusion.
- Demands cross-team standardization for reproducibility in device preparation and cell loading.
- Adaptable to various cell types and tissue models with protocol optimization.
- Critical steps include precise cell introduction and gel handling to prevent leakage and ensure network integrity.
Biopharma FAQs
Why does null hypothesis testing matter for vascular network validation?
Null hypothesis testing enables objective assessment of whether the integrated vascular network significantly improves nutrient delivery and tissue viability compared to non-perfused controls, supporting robust target validation in engineered tissue models.
How does independent variable isolation fit the microfluidic perfusion workflow?
Isolating variables such as angiogenic factor concentration or cell type within the microfluidic device allows precise evaluation of their impact on vascular network formation and perfusion, strengthening discovery-stage mechanistic insights.
What do quantitative perfusion measurements enable in this tissue model?
Quantitative measurements of FITC-dextran flow and vascular connectivity provide actionable data on network integrity and functional perfusion, enabling comparison of experimental conditions and supporting data-driven advancement decisions.
Why are replication requirements critical for cross-functional collaboration?
Replicating vascular network formation and perfusion across devices ensures reproducibility, facilitating reliable data sharing and integration between discovery, screening, and translational teams in biopharma R&D.
What statistical analysis capabilities are required before implementing perfused spheroid assays?
Robust statistical analysis of perfusion efficiency, network formation rates, and tissue viability is essential to validate assay performance and support confident integration into screening and preclinical workflows.
![Development and Characterization of In Vitro Microvessel Network and Quantitative Measurements of Endothelial [Ca2+]i and Nitric Oxide Production](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F54014.jpg%3Fv%3D2026-08-26T10%253A21%253A11.000Z&w=384&q=75)
